KSC 2018 | 62nd Annual Scientific Meeting of The Korean Society of Cardiology

학술 프로그램

현재 페이지 경로: > Program > 학술 프로그램

전체보기

08:40-10:10

New Frontiers in Cardiology 1

Past, Present and Future of Cardiology

Theatre

Chairpersons	Seung-Jung Park, Dae-Won Sohn, Moon-Hyoung Lee
Panel	Il Suh, Tae Jin Youn, Young-Hoon Jeong, Iksung Cho
08:40-09:00	Past, Present and Future of Digital Medicine	[Speaker] Evan Muse/Scripps Translational Science Institute, USA
09:00-09:20	Past, Present and Future of Myocardial Imaging	[Speaker] Jeroen Bax/Leiden Univ., Netherlands
09:20-09:40	Past, Present and Future of Cardiac Epidemiology	[Speaker] Katsuyuki Miura/Shiga Univ., Japan
09:40-10:00	Past, Present and Future of Antithrombotic Therapy	[Speaker] Matthew Todd Roe/Duke Univ., USA
10:00-10:10	Discussion

Myocardial Infarction 1

The Burden of Myocardial Infarction in the World

Grand 1

Chairpersons	Myung Ho Jeong, Jin Yong Hwang
Panel	Jong-Seon Park, Jang-Whan Bae, Seok Kyu Oh, Byung Ryul Cho
08:40-09:00	The Evolving Landscape of Myocardial Infarction Care and Outcomes in the United States: Insights from the ACTION and CathPCI Registries of the ACC-NCDR	[Speaker] John A. Spertus/Saint Luke's Mid America Heart Institute, USA
09:00-09:20	Myocardial Infarction Outcomes in Singapore: Data from the National Registry and SingCLOUD	[Speaker] Yeo, Khung Keong/National Heart Centre, Singapore
09:20-09:40	Pre-existing Chronic Kidney Disease Increases the Risk of Triggering Acute Myocardial Infarction Due to Asian Dust Exposure	[Speaker] Sunao Kojima/Kawasaki Medical School, Japan
09:40-10:00	Current Status of Korean Registry of Acute Myocardial Infarction: Prospects and Barriers	[Speaker] Juhan Kim/Chonnam National Univ., Korea
10:00-10:10	Discussion

Basic Research 1

Drug Development and Therapy

Grand 2

Chairpersons	Youngkeun Ahn, Jin Han
Panel	TaeHoon Kim, Pil-Ki Min, Hun-Jun Park, Sung Woo Cho, Hyung Joon Joo
08:40-08:55	Cardiotoxicity Testing Using Human Pluripotent Stem Cell-derived Cardiomyocytes	[Speaker] Gun Sik Cho/NEXEL, Korea
08:55-09:10	Mechanical Force-induced Activation of Platelet Integrin GPIIbIIIa	[Speaker] Chungho Kim/Korea Univ., Korea
09:10-09:25	Identification of Indothiazinone as a Natural Antithrombotics	[Speaker] Jong-Wha Jung/Kyungpook National Univ., Korea
09:25-09:40	Development of a Human “Kidney on a Chip” for Assessment of Drug/xenobiotic Toxicity	[Speaker] Edward Kelly/University of Washington, USA
09:40-10:10	Discussion

Women Heart Disease 1

Gender and Medicine

Grand 3

Chairpersons	Vera Regitz-Zagrosek, Wan Joo Shim
Panel	Ji-Young Park, Young Sup Byun, Mi Seung Shin, Hyun Ju Yoon, Kyung-Soon Hong
08:40-09:00	Gender Equality and Gender Dimension in Academic Research	[Speaker] Vera Regitz-Zagrosek/University Medicine Berlin, PZHK, Germany
09:00-09:20	Gender Aspects of Korean Medical Students & Medical Edcuation	[Speaker] Young-Mee Lee/Korea Univ., Korea
09:20-09:40	Personalized and Precision Medicine: The Importance of Sex and Gender	[Speaker] Hack Lyoung Kim/Seoul National Univ., Korea
09:40-10:00	Gender Aspects of Risk Factors for Dementia	[Speaker] Yi-Sook Jung/Ajou Univ., Korea
10:00-10:10	Discussion

Cardiometabolic Syndrome 1

Crosstalk between Vascular Calcification and Cardiometabolic Syndrome

Grand 4

Chairpersons	Kwang Kon Koh, Jae-Kwan Song
Panel	Mi Jeong Kim, Sang-Hyun Ihm, Seung Hwan Han
08:40-09:05	Role of Vascular Smooth Muscle Cell Calcification	[Speaker] Yabing Chen/University of Alabama at Birmingham, USA
09:05-09:20	Role of Progenitor Cells in Vascular Calcification	[Speaker] Hyun-Jai Cho/Seoul National Univ., Korea
09:20-09:35	Aortic Valve Calcification and DPP4 Inhibition	[Speaker] Bongkun Choi/Ulsan Univ., Korea
09:35-09:50	Inflammatory and Metabolic Mechanisms Underlying Calcific Aortic Valve	[Speaker] Il Suk Sohn/Kyung Hee Univ., Korea
09:50-10:10	Discussion

Heart Failure 1

Multidisciplinary Team Approach in HF Management

Walker 2

Chairpersons	Young Dae Kim, Eun Seok Jeon
Panel	Myung A Kim, Sang-Ho Jo, Eui-Young Choi, Kyung-Kuk Hwang
08:40-09:00	Multidisciplinary Team Approach: Tips and Pearls	[Speaker] Jung Hyun Choi/Pusan National Univ., Korea
09:00-09:20	The Multidisciplinary Team Must Deliver Multifaceted Therapy	[Speaker] John McMurray/University of Glasgow, UK
09:20-09:35	Role of Nurse Cordinator in HF Management	[Speaker] Yeonsoo Jang/Yonsei Univ., Colleage of Nursing, Korea
09:35-09:50	Role of Clinical Exercise Physiologist in Heart Failure	[Speaker] Kee Chan Joo/Seowon Univ., Korea
09:50-10:10	Discussion

Imaging 1

Multimodal Imaging Approach for Infiltrative Heart Disease

Cosmos

Chairpersons	최연현, 조인호
Panel	구현정, 박철환, 조상건
08:40-09:00	Introduction of Infiltrative Heart Disease; Clinical and Pathololigical Viewpoint	[Speaker] 이상철/성균관의대
09:00-09:20	Cardiac MRI in Infiltrative Heart Disease	[Speaker] 정정임/가톨릭의대
09:20-09:40	Echo in the Diagnsis and Therapeutic Approach for Cardiac Sarcoidosis and Amyloidosis	[Speaker] 심지영/연세의대
09:40-10:00	Recent Advances of Cardiac PET in Sarcoidosis and Amyloidosis	[Speaker] 팽진철/서울의대
10:00-10:10	Discussion

10:20-11:50

Late Breaking & Featured Research from Asia-Pacific 1

Theatre

Chairpersons	Si Hoon Park, Donghoon Choi
Panel	Choong-Won 'Rick' Go, Moo Hyun Kim, Byeong-Keuk Kim, Young Hak Kim, Yongwhi Park, Ki Hong Lee, Young-Hoon Jeong, Jung Rae Cho
10:20-10:32	6-month Versus 12-month or Longer Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE): A Randomised, Open-label, Non-inferiority Trial	[Speaker] Young Bin Song/Sungkyunkwan Univ., Korea
10:32-10:35	Critique	[Speaker] Jung Rae Cho/Hallym Univ., Korea
10:35-10:38	Discussion
10:38-10:50	Ethnic Differences in Ischemia/Bleeding Tradeoff: Meta-Analysis of 7 RCTs	[Speaker] Jeehoon Kang/Seoul National Univ., Korea
10:50-10:53	Critique	[Speaker] Yongwhi Park/Gyeongsang National Univ., Korea
10:53-10:56	Discussion
10:56-11:08	Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease	[Speaker] Pil Hyung Lee/Ulsan Univ., Korea
11:08-11:11	Critique	[Speaker] Choong-Won 'Rick' Go/Hallym Univ., Korea
11:11-11:14	Discussion
11:14-11:26	COronary Computed Tomographic ANgiography for SElective Cardiac Catheterization Relation to CardioVascular Outcomesand Economics	[Speaker] Hyuk-Jae Chang/Yonsei Univ., Korea
11:26-11:29	Critique	[Speaker] Young Hak Kim/Ulsan Univ., Korea
11:29-11:32	Discussion
11:32-11:44	What Is the Ideal Blood Pressure in Patients with Atrial Fibrillation?: A Nationwide Cohort Study	[Speaker] Boyoung Joung/Yonsei Univ., Korea
11:44-11:47	Critique	[Speaker] Ki Hong Lee/Chonnam National Univ., Korea
11:47-11:50	Discussion

Intervention 1

40 Years of PCI: From Basic to Beyond

Grand 1

Chairpersons	David J. Moliterno, Seung-Jung Park
Panel	Woong Chol Kang, Sung Woo Kwon, Kyung Soo Kim, Jang Ho Bae, Junghan Yoon, Seung Jea Tahk, Jung-Kyu Han
10:20-10:35	PCI as a Therapy: Avoiding the Oculo-stenotic Reflex and Tunel Vision	[Speaker] Jun-Hee Lee/Hallym Univ., Korea
10:35-10:50	PCI Impact: Symptom, QOL, or Survival?	[Speaker] John A. Spertus/Saint Luke's Mid America Heart Institute, USA
10:50-11:05	Using Imaging to Optimize Therapy: In What Situations Can IVUS/OCT Help Me?	[Speaker] So-Yeon Choi/Ajou Univ., Korea
11:05-11:20	What Is FFR and How I Can Incorporate It into My Daily Practice?	[Speaker] Joo Myung Lee/Sungkyunkwan Univ., Korea
11:20-11:35	40 Years of PCI: Where Next?	[Speaker] Robert A. Byrne/Deutsches Herzzentrum Munchen, Germany
11:35-11:50	Discussion

Basic Research 2

The Fire of Life: Cardiac Energy Metabolism

Grand 2

Chairpersons	Ki Hwan Kwon, Seung Hwan Han
Panel	Ki-Seok Kim, Yong Sook Kim, TaeHoon Kim , Hyoung Kyu Kim, Soon Jun Hong
10:20-10:35	Somatic Mutations That Contribute to Clonal Hematopoiesis and Cardio-metabolic Disease	[Speaker] Kenneth Walsh/Boston Univ.,USA
10:35-10:50	White to Beige Conversion in PDE3B KO Adipose Tissue through Activation of AMPK Signaling and Mitochondrial Function	[Speaker] Youn Wook Chung/Yonsei Univ., Korea
10:50-11:05	Disoriented Choline Metabolism Promotes Pathologies in the Failing Heart	[Speaker] Ippei Shimizu/Niigata Univ., Japan
11:05-11:20	Enhanced-autophagy by Exenatide Mitigates Doxorubicin-induced Cardiotoxicity	[Speaker] Kyung-Hye Lee/Kyung Hee Univ., Korea
11:20-11:50	Discussion

Women Heart Disease 2

Update CVD in Women

Grand 3

Chairpersons	윤호중, 김명아
Panel	김미정, 나진오, 박상민, 박성지, 손일석
10:20-10:40	Are Women Adequately Diagnosed and Treated for Cardiovascular Diseases?	[Speaker] Vera Regitz-Zagrosek/University Medicine Berlin, PZHK, Germany
10:40-11:00	Antihypertensive Drug Therapy in Women: Do We Really Need to Consider the Gender?	[Speaker] 최성훈/한림의대
11:00-11:20	Sex Differences in Acute Decompensated Heart Failure	[Speaker] 유승기/을지의대
11:20-11:40	Ischemia and Non-Obstructive CAD and Coronary Microvascular Dysfunction	[Speaker] 박성미/고려의대
11:40-11:50	Discussion

Cardiometabolic Syndrome 2

Current Status of Cardiometabolic Syndrome

Grand 4

Chairpersons	서홍석, 편욱범
Panel	박찬석, 손정우, 우종신, 최철웅
10:20-10:35	Diabetes Fact Sheet	[Speaker] 이재혁/명지병원
10:35-10:50	Hypertension Fact Sheet	[Speaker] 김현창/연세의대
10:50-11:05	Dyslipidemia Fact Sheet	[Speaker] 유성훈/한양의대
11:05-11:20	Korea Survey of Cardiometabolic Syndrome, KSCMS Fact Sheet	[Speaker] 성기철/성균관의대
11:20-11:35	Future Perspectives in Cardiometabolic Syndrome	[Speaker] 김상현/서울의대
11:35-11:50	Discussion

Myocardial Infarction 2

Therapeutic Decisions beyond Guideline

Grand 5

Chairpersons	김효수, 차광수
Panel	김원, 나득영, 이장훈, 이중희, 장기육
10:20-10:40	Invasive Strategies after NSTE-ACS: Timing and Controversies	[Speaker] 허정호/고신의대
10:40-11:00	High-intensity Statins or Non-statin Combination in AMI: Which Do You Prefer?	[Speaker] 심두선/전남의대
11:00-11:20	Mechanical Complication Management after AMI: Do’s and Don’ts	[Speaker] 김정수/부산의대
11:20-11:40	Acute Cardiogenic Shock: Culprit Only vs. Immediate Multivessel PCI	[Speaker] 윤창환/서울의대
11:40-11:50	Discussion

Arrhythmia 1

ECG Review Course

Walker 1

Chairpersons	이명용, 장성원
		[Speaker] 박예민/가천의대
		[Speaker] 조영진/서울의대
		[Speaker] 이광노/고려의대
		[Speaker] 박종성/동아의대
		[Speaker] 김동민/단국의대
		[Speaker] 안진희/부산의대
		[Speaker] 신동금/한림의대
		[Speaker] 정래영/전북의대
		[Speaker] 김기훈/인제의대
		[Speaker] 이혜영/인제의대

Heart Failure 2

Advanced Heart Failure

Walker 2

Chairpersons	유규형, 강석민
Panel	김경희, 김인철, 정욱진, 조양현
10:20-10:37	What's the Advanced Heart Failure?	[Speaker] 윤종찬/한림의대
10:37-10:54	(Emerging) Pharmacological Tx for Advanced Heart Failure	[Speaker] 이주희/충북의대
10:54-11:11	Current Problems of Heart Transplantation in Korea	[Speaker] 최진오/성균관의대
11:11-11:28	Role of MCS in Advanced Heart Failure	[Speaker] 정성호/울산의대
11:28-11:50	Discussion

Imaging 2

Coronary Artery Bypass Graft Surgery; Contemporary Practice in 2018

Cosmos

Chairpersons	송재관, 윤영남
Panel	김형관, 이원우, 정동섭, 팽진철
10:20-10:40	Myocardial Viability for Therapeutic Approach to Ischemic Heart Disease	[Speaker] Jeroen Bax/Leiden Univ., Netherlands
10:40-11:00	Role of Radiologist in the Preoperative Assessment	[Speaker] 서영주/연세의대
11:00-11:20	Recent Advance of SPECT and PET in Preoperative Assessment	[Speaker] 조상건/전남의대
11:20-11:40	Prediction of Myocardial Viability; Case Presentation with Multi-modality Imaging Approach	[Speaker] 최의영/연세의대
11:40-11:50	Discussion

12:00-12:40

Scientific Session 1 [Bayer]

Tailored Protection for Your Cardio-Vascular Patients

Theatre

Chairpersons	조정관, 전은석
12:00-12:20	Considering Renal Outcomes in Anticoagulation Treatment with Rivaroxaban	[Speaker] 임홍의/고려의대
12:20-12:40	Evolving Antithrombotic Therapy for NVAF Patients with Heart Failure. Is It Enough?	[Speaker] 최진오/성균관의대

Diamond Session [Pfizer/BMS]

Strategies to Optimize Management of Atherosclerotic CVD and Stroke Prevention in Atrial Fibrillation

Grand 1

Chairpersons	김영훈, 김효수
12:00-12:20	ASCOT Legacy: Long-term Survival Benefit of BP, Lipid Lowering	[Speaker] 홍영준/전남의대
12:20-12:40	Choice of Antithrombotic Therapy in NVAF and Concomitant Coronary Artery Disease	[Speaker] Ziad Hijazi/Uppsala Univ., Sweden

Scientific Session 2 [Daewoong/Daiichisankyo]

Effective Treatments of Hypertension and Dyslipidemia

Walker 1

Chairpersons	안태훈, 편욱범
12:00-12:20	Update in Hypertension Guideline	[Speaker] 이해영/서울의대
12:20-12:40	ROSUVASTATIN In Early Prevention of CVD	[Speaker] 성지동/성균관의대

Scientific Session 3 [Novartis]

ARNI : PARADIGM Shift in Heart Failure Therapy

Walker 2

Chairpersons	김기식, 김재중
12:00-12:30	Resolving Dilemmas in the Treatment of Heart Failure	[Speaker] John McMurray/University of Glasgow, UK
12:30-12:40	Discussion

14:00-15:30

Cross Specialty 1

NOAC in CAD and PAD

Theatre

Chairpersons	Robert C. Welsh, Yun Shik Choi
Panel	Hiroshi Ando, Robert A. Byrne, Jum Seok Ko, Jin-Seok Kim, Deuk Young Nah, Kyung Woo Park, So Ryoung Lee
14:00-14:15	NOAC Role in ACS: Alternative or Addictive to DAPT - Still Promising?	[Speaker] Young-Hoon Jeong/Gyeongsang National Univ., Korea
14:15-14:30	NOAC for Stable CAD & PAD: COMPASS Impact in Real-World	[Speaker] Matthew Todd Roe/Duke Univ., USA
14:30-14:45	Appropriate Anticoagulation in AF Patients Undergoing Procedure: PCI and Ablation	[Speaker] Ki Hong Lee/Chonnam National Univ., Korea
14:45-15:00	Easy Tip to Use NOAC in AF Patients	[Speaker] Jung Myung Lee/Kyung Hee Univ., Korea
15:00-15:15	Management of Bleeding in AF Patients with NOAC	[Speaker] Myung-jin Cha/Seoul National Univ., Korea
15:15-15:30	Discussion

Myocardial Infarction 3

Current Practice and Debate

Grand 1

Chairpersons	성인환, 박헌식
Panel	김용철, 이장훈, 조정래, 조진만, 황경국
14:00-14:20	Erosion or Plaque Rupture: Which Is It? How to Do?	[Speaker] 윤혁준/계명의대
14:20-14:40	Aspiration Thrombectomy in Primary PCI: Dead or Alive?	[Speaker] 김동기/인제의대
14:40-15:00	Chronic Use of Antiplatelet and Antithrombotic Therapies in AF PCI: Choice and Duration	[Speaker] 박용휘/경상의대
15:00-15:20	Interrogation of Concomitant Non-culprit Stenoses in Patients with AMI: When and How?	[Speaker] 안성균/연세원주의대
15:20-15:30	Discussion

JCS-KSC Joint

Drug Discovery for Heart Failure

Grand 2

Chairpersons	Tohru Minamino, Sang Hong Baek
14:00-14:15	BIO((2’z, 3’E)-6-Bromoindirubin-3’-oxime)	[Speaker] Youngkeun Ahn/Chonnam National Univ., Korea
14:15-14:30	Targeting Metabolites for HF Treatment	[Speaker] Tohru Minamino/Niigata Univ., Japan
14:30-14:45	Cardiac Myosin Activator	[Speaker] Eun Seok Jeon/Sungkyunkwan Univ., Korea
14:45-15:00	Hippo-YAP Pathway	[Speaker] Norifumi Takeda/University of Tokyo, Japan
15:00-15:30	Discussion

Lipid 1

Progression and Regression of Atherosclerosis

Grand 3

Chairpersons	김효수, 정익모
Panel	김주한, 김중선, 이은미, 최성훈, 최윤석
14:00-14:20	Lipid and Inflammation in Atherosclerosis	[Speaker] 김장영/연세원주의대
14:20-14:40	Anti-inflammtory Therapy on Atherosclerosis	[Speaker] 이왕수/중앙의대
14:40-15:00	What Do FOURIER or ODYSSEY Data Mean for Clinical Practice?	[Speaker] 박훈준/가톨릭의대
15:00-15:20	Ongoing Development of New Therapy for Atherosclerosis	[Speaker] 김상현/서울의대
15:20-15:30	Discussion

Echo 1

Imaging in Heart Failure

Walker 2

Chairpersons	김기식, 신준한
Panel	김계훈, 신미승, 조구영
14:00-14:15	Echo in HFpEF	[Speaker] 박찬석/가톨릭의대
14:15-14:30	Strain Imaging in HF	[Speaker] 이주희/충북의대
14:30-14:45	Vortex Imaging in Heart Failure	[Speaker] 홍그루/연세의대
14:45-15:00	Imaging for ECMO	[Speaker] 손일석/경희의대
15:00-15:15	Imaging for LVAD	[Speaker] 김은경/성균관의대
15:15-15:30	Discussion

Smart Healthcare

Use of Smart Health Techonologies and Big Data Analysis for Cardiovascular Research

Cosmos

Chairpersons	Seung Woo Park, Hyuk-Jae Chang
Panel	In-Cheol Kim, Hack Lyoung Kim, In-Jeong Cho
14:00-14:30	Improving Medical Adherence in Cardiovascular Disease Management with mHealth Technologies	[Speaker] Evan Muse/Scripps Translational Science Institute, USA
14:30-14:50	Are There Differences in the Efficacy of Dual Combination of RAS Inhitors + CCBs, RAS Inhibitors + Diuretics vs CCBs + Diuretics for Treatment of Hypertension? Analysis from the OHDSI Network	[Speaker] Sung Ha Park/Yonsei Univ., Korea
14:50-15:10	Application of EMR Based Big Data Registry for Cardiovascular Disease	[Speaker] Hye Jin Kam/Health Innovation Bigdata Center, Asan Medical Center, Korea
15:10-15:30	Discussion

15:40-17:10

Late Breaking & Featured Research from Korea

Theatre

Chairpersons	심완주, 안영근
Panel	권택근, 김송이, 박근호, 손일석, 이진배, 최종일, 한진, 홍영준
15:40-15:55	Role of Cardiac Fibroblast in Pressure Induced Cardiac Injury	[Speaker] Ki-Seok KIM
15:55-16:00	Discussion
16:00-16:15	Identification on Preventive Mechanism of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor for Atherosclerosis in Normoglycemic Rabbit Model	[Speaker] Jung-Sun KIM
16:15-16:20	Discussion
16:20-16:35	The Feasibility of Handgrip Exercise Echocardiography for Detection of Heart Failure with Preserved Ejection Fraction Compared to Supine Bicycle Exercise Cardiac Catheterization Test	[Speaker] Seok-Jae HWANG
16:35-16:40	Discussion
16:40-16:55	Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-induced Heart Failure SGLT2 Inhibitor Prevents Doxorubicin-induced Cardiotoxicity	[Speaker] Sungsoo CHO
16:55-17:00	Discussion

Intervention 2

Hot Issues in Antithrombotic Therapy

Grand 1

Chairpersons	Matthew Todd Roe, Yangsoo Jang
Panel	Robert C. Welsh, Kyung Woo Park, Duk Woo Park, Yongwhi Park, Jong-Seon Park, Jang-Whan Bae, Young Bin Song, Young-Hoon Jeong
15:40-15:55	Expanding the Role of NOACs: Post PCI and Post TAVR?	[Speaker] David J. Moliterno/University of Kentucky, USA
15:55-16:10	Expanding the Role of NOACs: ACS and ASCVD	[Speaker] Matthew Todd Roe/Duke Univ., USA
16:10-16:25	P2Y12 Escalation and De-Escalation Strategy in Clinical Practice	[Speaker] Jung Rae Cho/Hallym Univ., Korea
16:25-16:40	New Trials on P2Y12 Intensity and Durations: GLOBAL-LEADER, TWILIGHT, and More	[Speaker] Robert A. Byrne/Deutsches Herzzentrum Munchen, Germany
16:40-16:55	Criteria and Clinical Decision for DAPT Duration after PCI	[Speaker] Kyung Woo Park/Seoul National Univ., Korea
16:55-17:10	Discussion

Lipid 2

Cardiometabolic Risk Factors beyond Lipids

Grand 3

Chairpersons	김치정, 최동훈
Panel	강현재, 임영효, 조현재, 홍순준
15:40-16:00	Epidemiologic Assessment of the Main Determinants of Cardiometabolic Disease	[Speaker] 최윤석/가톨릭의대
16:00-16:20	The Role of Diet in Cardiometabolic Disease	[Speaker] 신민정/고려대학교
16:20-16:40	Exercise for the Cardiometabolic Disease	[Speaker] 김영주/성신여대
16:40-17:00	Gut Microbiome and Cardiometabolic Disease	[Speaker] 주형준/고려의대
17:00-17:10	Discussion

Arrhythmia 2

Stroke Summit

Walker 1

Chairpersons	김준수, 김대경
Panel	강구현, 권창희, 백용수, 이찬희, 차명진
15:40-15:50	Care Burden of AF	[Speaker] 양필성/차의대
15:50-16:00	New AF Screening	[Speaker] 김남호/원광의대
16:00-16:10	Risk Stratification of Stroke and Thromboembolism in AF	[Speaker] 김태훈/연세의대
16:10-16:20	NOAC Use in Specific Conditions	[Speaker] 진은선/경희의대
16:20-16:30	LAA Occluder	[Speaker] 임홍의/고려의대
16:30-16:45	Korean AF Guideline	[Speaker] 정보영/연세의대
16:45-17:10	Discussion

Echo 2

Valvular Heart Diseases

Walker 2

Chairpersons	Jong-Won Ha, Jong-Min Song
Panel	Yong-Jin Kim, Tae-Ho Park, Sangchol Lee
15:40-15:55	Echocardiography in TAVR	[Speaker] Woo-Baek Chung/Catholic Univ., Korea
15:55-16:10	Roles of CT and MRI for Aortic Valvular Stenosis Evaluation	[Speaker] Yeon Hyen Choe/Sungkyunkwan Univ., Korea
16:10-16:25	Echocardiography in Mitral Regurgitation	[Speaker] Chi Young Shim/Yonsei Univ., Korea
16:25-16:40	Echocardiography in Prosthetic Valves	[Speaker] Sahmin Lee/Ulsan Univ., Korea
16:40-16:55	Intraoperative TEE; Case-based Learning	[Speaker] Sung Ji Park/Sungkyunkwan Univ., Korea
16:55-17:10	Discussion

Epidemiology

Improvement of CVD Prediction in the General Population

Cosmos

Chairpersons	Il Suh, Sang Hong Baek
Panel	Young Hak Kim, Ki Chul Sung, Ju-Mi Lee
15:40-16:00	Improving Disease Prediction with Machine Learning	[Speaker] Choongki Min/Selvas AI, Korea
16:00-16:20	CVD Predictions Using Repeatedly Measured Risk Factors	[Speaker] Hyeon Chang Kim/Yonsei Univ., Korea
16:20-16:40	Imaging Techniques to Improve CVD Prediction	[Speaker] Hyung-Bok Park/Catholic Kwandong Univ., Korea
16:40-17:00	The Improvement of CVD Prediction for Japanese Population	[Speaker] Katsuyuki Miura/Shiga Univ., Japan
17:00-17:10	Discussion